Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

MDxHealth SA ADR

MDXH
Current price
1.75 USD -0.05 USD (-2.78%)
Last closed 1.91 USD
ISIN US58286E1029
Sector Healthcare
Industry Diagnostics & Research
Exchange NASDAQ
Capitalization 100 479 520 USD
Yield for 12 month -43.91 %
1Y
3Y
5Y
10Y
15Y
MDXH
21.11.2021 - 28.11.2021

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its testing solutions includes Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; and Resolved mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection. The company offers genomic prostate score which provides personalized genomic insights to both physicians and patients navigating the complexities of prostate cancer diagnosis and treatment. It sells its products through urology sales force, consisting of direct sales representatives, strategic account managers, and regional sales managers. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium. Address: CAP Business Center, Herstal, Belgium, 4040

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

7.87 USD

P/E ratio

Dividend Yield

Current Year

+70 193 000 USD

Last Year

+37 054 000 USD

Current Quarter

+22 159 000 USD

Last Quarter

+19 834 000 USD

Current Year

+39 435 000 USD

Last Year

+19 219 000 USD

Current Quarter

+12 163 000 USD

Last Quarter

+10 938 000 USD

Key Figures MDXH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -18 621 000 USD
Operating Margin TTM -32.38 %
PE Ratio
Return On Assets TTM -11 %
PEG Ratio
Return On Equity TTM -457.29 %
Wall Street Target Price 7.87 USD
Revenue TTM 80 741 000 USD
Book Value 0.26 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 32.3 %
Dividend Yield
Gross Profit TTM 19 219 000 USD
Earnings per share -1.48 USD
Diluted Eps TTM -1.48 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -50.54 %

Dividend Analytics MDXH

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History MDXH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:10
Payout Ratio
Last Split Date 14.11.2023
Dividend Date

Stock Valuation MDXH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.6819
Price Sales TTM 1.2445
Enterprise Value EBITDA -2.7262
Price Book MRQ 3.5479

Financials MDXH

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators MDXH

For 52 weeks

1.95 USD 4.64 USD
50 Day MA 2.27 USD
Shares Short Prior Month 42 803
200 Day MA 2.74 USD
Short Ratio 0.18
Shares Short 29 361
Short Percent 0.08 %